$PLL
Piedmont Lithium Inc.

2023 Q3 Form 10-Q Financial Statement

#000172820523000052 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $47.13M $0.00 $0.00
YoY Change
Cost Of Revenue $23.36M $0.00
YoY Change
Gross Profit $23.76M $0.00
YoY Change
Gross Profit Margin 50.43%
Selling, General & Admin $11.19M $11.98M $7.675M
YoY Change 53.84% 56.05% -17.87%
% of Gross Profit 47.07%
Research & Development $410.0K $389.3K $662.9K
YoY Change 35.4% -41.28% -93.61%
% of Gross Profit 1.73%
Depreciation & Amortization $60.00K $60.78K $6.146K
YoY Change 182.13% 888.94% 346.66%
% of Gross Profit 0.25%
Operating Expenses $11.66M $12.43M $8.344M
YoY Change 53.48% 48.93% -57.72%
Operating Profit $15.96M -$15.10M -$8.344M
YoY Change -266.3% 80.99% 11.56%
Interest Expense $8.000K $11.16K -$33.93K
YoY Change -61.24% -132.9% -46.33%
% of Operating Profit 0.05%
Other Income/Expense, Net $8.959M $5.112M -$81.69K
YoY Change -69.82% -6357.75%
Pretax Income $24.90M -$10.00M -$9.600M
YoY Change 23.88% 4.17% 26.32%
Income Tax $2.000M $600.0K $0.00
% Of Pretax Income 8.03%
Net Earnings $22.89M -$10.64M -$9.581M
YoY Change 37.36% 11.04% 25.53%
Net Earnings / Revenue 48.57%
Basic Earnings Per Share $1.19 -$0.55 -$0.53
Diluted Earnings Per Share $1.19 -$0.55 -$0.53
COMMON SHARES
Basic Shares Outstanding 19.20M shares 19.18M shares 17.93M shares
Diluted Shares Outstanding 19.24M shares 19.19M shares 17.93M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $95.00M $89.22M $139.0M
YoY Change -19.21% -35.83% -2.54%
Cash & Equivalents $94.50M $88.75M $139.0M
Short-Term Investments $500.0K $470.9K
Other Short-Term Assets $4.374M $4.905M $4.460M
YoY Change 30.1% 9.96% 256.45%
Inventory
Prepaid Expenses
Receivables $23.28M
Other Receivables $0.00
Total Short-Term Assets $122.2M $93.65M $143.5M
YoY Change 0.99% -34.73% -0.28%
LONG-TERM ASSETS
Property, Plant & Equipment $116.4M $101.7M $53.69M
YoY Change 80.94% 89.38% 7297.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $133.0M $124.0M $64.23M
YoY Change 37.39% 93.11% 294.98%
Other Assets $25.73M $23.56M $11.62M
YoY Change 63.61% 102.65% 5119.86%
Total Long-Term Assets $275.2M $249.3M $129.6M
YoY Change 55.56% 92.42% 194.78%
TOTAL ASSETS
Total Short-Term Assets $122.2M $93.65M $143.5M
Total Long-Term Assets $275.2M $249.3M $129.6M
Total Assets $397.4M $342.9M $273.0M
YoY Change 33.4% 25.6% 45.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.60M $12.15M $1.613M
YoY Change 1665.87% 653.24% -37.04%
Accrued Expenses $3.991M
YoY Change 66.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $201.0K $277.3K $504.9K
YoY Change -56.17% -45.07% -53.48%
Total Short-Term Liabilities $42.86M $12.72M $6.139M
YoY Change 495.1% 107.17% -1.22%
LONG-TERM LIABILITIES
Long-Term Debt $44.00K $72.10K $349.4K
YoY Change -82.02% -79.37% -71.51%
Other Long-Term Liabilities $1.200M $1.254M
YoY Change -0.85%
Total Long-Term Liabilities $44.00K $72.10K $349.4K
YoY Change -82.02% -79.37% -71.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.86M $12.72M $6.139M
Total Long-Term Liabilities $44.00K $72.10K $349.4K
Total Liabilities $49.30M $17.50M $6.488M
YoY Change 295.31% 169.73% -12.8%
SHAREHOLDERS EQUITY
Retained Earnings -$102.0M -$124.9M -$111.4M
YoY Change 7.59% 12.12% 56.24%
Common Stock $2.000K $1.919K $1.796K
YoY Change 11.17% 6.85% 15.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $348.1M $325.4M $266.6M
YoY Change
Total Liabilities & Shareholders Equity $397.4M $342.9M $273.0M
YoY Change 33.4% 25.6% 45.35%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $22.89M -$10.64M -$9.581M
YoY Change 37.36% 11.04% 25.53%
Depreciation, Depletion And Amortization $60.00K $60.78K $6.146K
YoY Change 182.13% 888.94% 346.66%
Cash From Operating Activities $25.09M -$10.18M $50.00K
YoY Change -699.15% -20451.74% -100.31%
INVESTING ACTIVITIES
Capital Expenditures $16.28M -$1.914M -$13.92M
YoY Change 13.13% -86.25% -23.53%
Acquisitions
YoY Change
Other Investing Activities -$2.540M -$32.09M -$3.467M
YoY Change -6.48% 825.67% -78.81%
Cash From Investing Activities -$18.81M -$30.18M -$17.39M
YoY Change 9.96% 73.53% -49.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -530.0K -121.3K -481.5K
YoY Change 250.99% -74.81% -100.28%
NET CHANGE
Cash From Operating Activities 25.09M -10.18M 50.00K
Cash From Investing Activities -18.81M -30.18M -17.39M
Cash From Financing Activities -530.0K -121.3K -481.5K
Net Change In Cash 5.750M -40.47M 50.00K
YoY Change -126.81% -81049.96% -99.96%
FREE CASH FLOW
Cash From Operating Activities $25.09M -$10.18M $50.00K
Capital Expenditures $16.28M -$1.914M -$13.92M
Free Cash Flow $8.810M -$8.262M $13.97M
YoY Change -147.42% -159.13% 616.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88748419 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99246963 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4904795 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2611841 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
93653214 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
101858804 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101685472 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71540798 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23556684 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18873679 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
124040126 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
95647802 usd
CY2023Q2 us-gaap Assets
Assets
342935496 usd
CY2022Q4 us-gaap Assets
Assets
287921083 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12149805 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12861514 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
277316 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
425187 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
290768 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
124464 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12717889 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13411165 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
72099 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
163425 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1253561 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1176709 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3456971 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2881123 usd
CY2023Q2 us-gaap Liabilities
Liabilities
17500520 usd
CY2022Q4 us-gaap Liabilities
Liabilities
17632422 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19195889 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19195889 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18073367 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18073367 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1919 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1807 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
456758193 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
381241814 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124936546 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105657674 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6388590 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5297286 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
325434976 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
270288661 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
342935496 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
287921083 usd
CY2023Q2 pll Exploration And Mine Development Costs
ExplorationAndMineDevelopmentCosts
440190 usd
CY2022Q2 pll Exploration And Mine Development Costs
ExplorationAndMineDevelopmentCosts
882874 usd
pll Exploration And Mine Development Costs
ExplorationAndMineDevelopmentCosts
1196964 usd
pll Exploration And Mine Development Costs
ExplorationAndMineDevelopmentCosts
1050712 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11986634 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7461365 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20608084 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13039370 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
12426824 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
8344239 usd
us-gaap Operating Expenses
OperatingExpenses
21805048 usd
us-gaap Operating Expenses
OperatingExpenses
14090082 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2675145 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1155379 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5417509 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4544882 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15101969 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9499618 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-27222557 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-18634964 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1165341 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
288 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1928791 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
288 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
11160 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
34214 usd
us-gaap Interest Expense
InterestExpense
25677 usd
us-gaap Interest Expense
InterestExpense
76610 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-17878 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-47759 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-67144 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-24649 usd
CY2023Q2 pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
3975337 usd
CY2022Q2 pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
0 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
7249869 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
0 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5111640 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-81685 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9085839 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100971 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9990329 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9581303 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18136718 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18735935 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
648811 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1142154 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10639140 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9581303 usd
us-gaap Net Income Loss
NetIncomeLoss
-19278872 usd
us-gaap Net Income Loss
NetIncomeLoss
-18735935 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.55
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.55
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.10
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19186640 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19186640 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17930926 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17930926 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18856995 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18856995 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17019262 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17019262 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10639140 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9581303 usd
us-gaap Net Income Loss
NetIncomeLoss
-19278872 usd
us-gaap Net Income Loss
NetIncomeLoss
-18735935 usd
CY2023Q2 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent
1121968 usd
CY2022Q2 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent
-342767 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent
-1091304 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent
-149123 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1121968 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-342767 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1091304 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-149123 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9517172 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9924070 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20370176 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18885058 usd
CY2023Q2 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent
96050 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent
-566306 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent
0 usd
CY2022Q2 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-19278872 usd
us-gaap Net Income Loss
NetIncomeLoss
-18735935 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4310353 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1382905 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5417509 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4544882 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
7249869 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1142154 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Depreciation
Depreciation
105798 usd
us-gaap Depreciation
Depreciation
11208 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
95697 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
60919 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-11542 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-12947 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-23824 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2018989 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1969142 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-80464 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-59430 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1072539 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-486145 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1071726 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2638479 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19688001 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17853851 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28695695 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11533913 usd
pll Advances Paid On Equity Method Investment
AdvancesPaidOnEquityMethodInvestment
4742466 usd
pll Advances Paid On Equity Method Investment
AdvancesPaidOnEquityMethodInvestment
7099355 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
28217574 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
10054904 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-61655735 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28688172 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
71084389 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
122059476 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
93326 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
239197 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
822066 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
70845192 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
121330736 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10498544 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
74788713 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99246963 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64244983 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88748419 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139033696 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6773298 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2004734 usd
us-gaap Interest Paid Net
InterestPaidNet
25677 usd
us-gaap Interest Paid Net
InterestPaidNet
76612 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
121749 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
122418 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
270288661 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
71084389 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1166038 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2023Q1 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
-2213272 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8639732 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
331686084 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3266064 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2023Q2 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
1121968 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10639140 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
325434976 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
161784606 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
93326 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
71626268 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
191163 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
85470 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101685472 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71540798 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets, fair value of stock-based compensation awards, income tax uncertainties, valuation of deferred tax assets, contingent assets and liabilities, legal claims, asset impairments, and environmental remediation. Actual results could differ due to the uncertainty inherent in the nature of these estimates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our estimates and assumptions on current facts, historical experience, and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from our estimates. To the extent there are material differences between estimates and actual results, future results of operations will be affected.</span></div>
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124900000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105700000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
101876635 usd
CY2023Q2 pll Equity Method Investments Number
EquityMethodInvestmentsNumber
3 investment
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
105395866 usd
CY2023Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
16126050 usd
CY2023Q2 pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
3975337 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2675145 usd
CY2023Q2 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent
1218018 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
124040126 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
95647802 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
28217574 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
7249869 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5417509 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent
-1657610 usd
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
57723058 usd
CY2022Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
8008697 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1155379 usd
CY2022Q2 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent
-342767 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
64233609 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
58872710 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
10054904 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4544882 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent
-149123 usd
CY2023Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
300000 usd
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
600000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
470889 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
483836 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4433906 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2128005 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4904795 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2611841 usd
CY2023Q2 pll Equity Method Investment Advances
EquityMethodInvestmentAdvances
21758906 usd
CY2022Q4 pll Equity Method Investment Advances
EquityMethodInvestmentAdvances
17316440 usd
CY2023Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
276933 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
263845 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1520845 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1293394 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23556684 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18873679 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
14000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3266064 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1591231 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
4436800 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
2356086 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
4698 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
850763 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3266064 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1591231 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4432102 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1505323 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3185380 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1510671 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4310353 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1382905 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
80684 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
80560 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
121749 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
122418 usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
3266064 usd
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
1591231 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
4432102 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
1505323 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
272504 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
135957 shares
CY2023Q1 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
0 shares
CY2022Q1 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
15000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
19458 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
374003 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
58949 shares
CY2023Q2 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
0 shares
CY2022Q2 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
37500 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
719 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
336469 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
394733 shares
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-10639140 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10639140 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9581303 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9581303 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-19278872 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-19278872 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19278872 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19278872 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-18735935 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18735935 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19186640 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19186640 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17930926 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17930926 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18856995 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18856995 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18856995 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18856995 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17019262 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17019262 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.55
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.55
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.10
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
530359 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500174 shares
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10000000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18700000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.065
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.063
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
pll Income Tax Expense Benefit Period Increase Decrease
IncomeTaxExpenseBenefitPeriodIncreaseDecrease
1100000 usd
CY2023Q2 us-gaap Other Commitment
OtherCommitment
11000000 usd
CY2023Q2 pll Community Development Agreement Parks And Recreation Projects Amount
CommunityDevelopmentAgreementParksAndRecreationProjectsAmount
1000000 usd
CY2023Q2 pll Community Development Agreement Amount Paid In Annual Installments
CommunityDevelopmentAgreementAmountPaidInAnnualInstallments
10000000 usd
CY2023Q2 pll Community Development Agreement Annual Payment Amount
CommunityDevelopmentAgreementAnnualPaymentAmount
500000 usd
CY2023Q2 pll Community Development Agreement Amount Paid In Annual Installments Period
CommunityDevelopmentAgreementAmountPaidInAnnualInstallmentsPeriod
P20Y
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001728205-23-000052-index-headers.html Edgar Link pending
0001728205-23-000052-index.html Edgar Link pending
0001728205-23-000052.txt Edgar Link pending
0001728205-23-000052-xbrl.zip Edgar Link pending
ex311-10q_q2x2023.htm Edgar Link pending
ex312-10q_q2x2023.htm Edgar Link pending
ex321-10q_q2x2023.htm Edgar Link pending
ex322-10q_q2x2023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pll-20230630.htm Edgar Link pending
pll-20230630.xsd Edgar Link pending
pll-20230630_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
pll-20230630_def.xml Edgar Link unprocessable
pll-20230630_lab.xml Edgar Link unprocessable
pll-20230630_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pll-20230630_cal.xml Edgar Link unprocessable
pll-20230630_pre.xml Edgar Link unprocessable